Literature DB >> 18195067

In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans.

Manuel Cuenca-Estrella1, Ana Alastruey-Izquierdo, Laura Alcazar-Fuoli, Leticia Bernal-Martinez, Alicia Gomez-Lopez, Maria J Buitrago, Emilia Mellado, Juan L Rodriguez-Tudela.   

Abstract

Activities of 35 combinations of antifungal agents against Scedosporium spp. were analyzed by a checkerboard microdilution design and the summation of fractional concentration index. An average indifferent effect was detected apart from combinations of azole agents and echinocandins against Scedosporium apiospermum. Antagonism was absent for all antifungal combinations against both species.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18195067      PMCID： PMC2258535          DOI： 10.1128/AAC.01160-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  23 in total

1.  Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans.

Authors:  E Petrikkou; J L Rodríguez-Tudela; M Cuenca-Estrella; A Gómez; A Molleja; E Mellado
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans.

Authors:  J Meletiadis; J W Mouton; J L Rodriguez-Tudela; J F Meis; P E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole.

Authors:  A Espinel-Ingroff; A Fothergill; M Ghannoum; E Manavathu; L Ostrosky-Zeichner; M Pfaller; M Rinaldi; W Schell; T Walsh
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 4.  Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist.

Authors:  Josep Guarro; A Serda Kantarcioglu; Regine Horré; Juan Luis Rodriguez-Tudela; Manuel Cuenca Estrella; Juan Berenguer; G Sybren de Hoog
Journal:  Med Mycol       Date:  2006-06       Impact factor: 4.076

5.  Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.

Authors:  Fèlix Gilgado; Carolina Serena; Josep Cano; Josepa Gené; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2006-10-02       Impact factor: 5.191

6.  In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Emilia Mellado; Guillermo Garcia-Effron; Araceli Monzon; Juan Luis Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

7.  Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.

Authors:  M Cuenca-Estrella; B Ruiz-Díez; J V Martínez-Suárez; A Monzón; J L Rodríguez-Tudela
Journal:  J Antimicrob Chemother       Date:  1999-01       Impact factor: 5.790

8.  Susceptibility of filamentous fungi to voriconazole tested by two microdilution methods.

Authors:  Maria José Linares; Guadalupe Charriel; Francisco Solís; Fernando Rodriguez; Ana Ibarra; M Casal
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

9.  Prevalence and susceptibility testing of new species of pseudallescheria and scedosporium in a collection of clinical mold isolates.

Authors:  Ana Alastruey-Izquierdo; Manuel Cuenca-Estrella; Araceli Monzón; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2006-11-13       Impact factor: 5.191

10.  Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Emilia Mellado; Maria J Buitrago; Araceli Monzon; Juan Luis Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191
View more
  17 in total

Review 1.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

2.  Experimental murine scedosporiosis: histopathology and azole treatment.

Authors:  M Mar Rodríguez; F Javier Pastor; Valentina Salas; Enrique Calvo; Emilio Mayayo; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

3.  Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.

Authors:  Michaela Lackner; G Sybren de Hoog; Paul E Verweij; Mohammad J Najafzadeh; Ilse Curfs-Breuker; Corné H Klaassen; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

4.  Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis.

Authors:  Florent Morio; Delphine Horeau-Langlard; Françoise Gay-Andrieu; Jean-Philippe Talarmin; Alain Haloun; Michelle Treilhaud; Philippe Despins; Frédérique Jossic; Laurence Nourry; Isabelle Danner-Boucher; Sabine Pattier; Jean-Philippe Bouchara; Patrice Le Pape; Michel Miegeville
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

Review 5.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 6.  Emerging fungal infections in solid organ transplant recipients.

Authors:  Shmuel Shoham
Journal:  Infect Dis Clin North Am       Date:  2013-04-17       Impact factor: 5.982

7.  Cerebral Scedosporium apiospermum infection presenting with intestinal manifestations.

Authors:  D Lin; Q Kamili; K Qurat-Ul-Ain; S Lai; D M Musher; R Hamill
Journal:  Infection       Date:  2013-02-26       Impact factor: 3.553

Review 8.  Fungus-Specific CD4 T Cells as Specific Sensors for Identification of Pulmonary Fungal Infections.

Authors:  Alexander Scheffold; Carsten Schwarz; Petra Bacher
Journal:  Mycopathologia       Date:  2017-11-22       Impact factor: 2.574

9.  Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans.

Authors:  M Mar Rodríguez; Enrique Calvo; Carolina Serena; Marçal Mariné; F Javier Pastor; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

10.  Identification of 14-α-Lanosterol Demethylase (CYP51) in Scedosporium Species.

Authors:  Anne Bernhardt; Wieland Meyer; Volker Rickerts; Toni Aebischer; Kathrin Tintelnot
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.